Company Overview and News

3
Insured Municipal Bonds May Offer Added Security For Investors

2018-07-20 seekingalpha
Puerto Rico's recent history of municipal bond defaults has highlighted the potential benefits of a niche part of the municipal (muni) bond market - insured municipal bonds. Insured munis accounted for 6% of all municipal issuance in the first half of 2018,1 but we believe these can play a role for investors who want assurance that their bonds' interest and principal will be paid on time - even if the issuer defaults.
AGO.PRE AGO.PRF AGO.PRB AGO IVZ

139
My 'Ten Commandments' Of Investing

2018-07-11 seekingalpha
In this letter, I wish to share with you our investment strategy and summarize for you the logic behind our investment activities.
BAMGF NNUTU NNUTD CALL RAD AGO BAMKF BAM

11
Amazon On Top Again

2018-06-11 seekingalpha
With Amazon a top 10 Portfolio Armor name again, I present a couple of ways longs can limit their risk in the event my site is wrong this time.
AGO.PRE AGO.PRF AGO.PRB AGO MANU

253
SA Interview: Investing With A Margin Of Safety With Tim Travis

2018-06-03 seekingalpha
Tim Travis is a veteran deep value investor, money manager and founder/CIO of T&T Capital Management.
AGO.PRE AGO.PRF BPOP AGO.PRB MET NFLX GOOG OFG.PRB OFG.PRA OFG.PRD SHLD KW OFGIP ALLY.PRA AMZN AGO OFG-B OFG-D AIG OFG-A EVTC BHF ALLY GOOGL TSLA OFG

6
Assured again sues Puerto Rico, board over fiscal plan

2018-05-23 reuters
NEW YORK, May 23 (Reuters) - Bond insurer Assured Guaranty sued Puerto Rico and its federally-appointed oversight board on Wednesday, saying their plan to resuscitate the storm-ravaged, bankrupt U.S. territory violates the U.S. Constitution by stripping creditors of property rights.
AGO.PRE AGO.PRF AGO.PRB AGO

42
Should You Give Einhorn The Green Light?

2018-05-21 seekingalpha
GLRE is a reinsurance company whose investment portfolio is managed by hedge fund manager David Einhorn (DME advisors).
BRK.A AGO.PRE BHF AGO.PRF GM.WS.A AGO.PRB GM.WS.B GM.WS.C AGO GM GM.WSB

8
Assured Guaranty: Leading Insurance Provider With 45.81% Discount

2018-05-16 seekingalpha
In fact, Assured Guaranty had a successful first quarter in 2018 and a long history of conservatively reserving for losses.
AGO.PRE AGO.PRF FNFV AGO.PRB FAF AGO MTG FNF

6
Syncora Announces NYDFS Approval of $400mm Payment to Third-Party Holders of Surplus Notes in Connection with Reinsurance, Surplus Noteholder Consent to Reinsurance Transaction and First Quarter 2018 Interim GAAP Consolidated Financial Results

2018-05-14 globenewswire
HAMILTON, Bermuda, May 14, 2018 (GLOBE NEWSWIRE) -- Syncora Holdings Ltd. (“Syncora” or the “Company”) today announced that the New York State Department of Financial Services has approved the proposed reinsurance transaction with Assured Guaranty Corp. and the related payment on the Syncora Guarantee Inc. (“SGI”) Long-Term Surplus Notes (the “Long-Term Surplus Notes”) and Short-Term Surplus Notes (the “Short-Term Surplus Notes" and, together with the Long-Term Surplus Notes, the “Surplus Notes”) held by third party holders in the amounts set forth below:
AGO.PRE AGO.PRF AGO.PRB AGO SYCRF

6
Puerto Rico bondholders pitch deal that could resolve a big dispute in island's debt restructuring

2018-05-14 cnbc
Warring creditor groups in Puerto Rico's ongoing debt restructuring have reached an agreement that could resolve one of the most contentious disputes in the more than $70 billion bankruptcy case.
AGO.PRE AGO.PRF AGO.PRB AGO

6
Assured Guaranty's (AGO) CEO Dominic Frederico on Q1 2018 Results - Earnings Call Transcript

2018-05-04 seekingalpha
Operator Good morning. And welcome to the Assured Guaranty First Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note today’s event is being recorded.
AGO.PRE AGO.PRF AGO.PRB AGO

7
AGO / Assured Guaranty Ltd. 10-Q ASSURED GUARANTY (Quarterly Report)

2018-05-04 sec.gov
Document Table of Contents
AGO

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to AGO / Assured Guaranty Ltd. on message board site Silicon Investor.

Chicago Bears Fan Club Agouron Pharmaceuticals (AGPH)
NovaGold Resources Inc. (NG) -NYSE MKT Chicago Bridge u0026 Iron Company N.V. (CBI)
CRNT: Ceragon Networks Ltd. NOVAGOLD RESOURCES INC. (TSE:NRI; OTC BB: NVGLF)
DragonflyPicks Dragon Systems, Inc. [DRGN]
PTG: Paragon Technologies Inc. MELu0027S PASSION OF CHRIST EVOKES SYNAGOGUEu0027S LOATHING
CUSIP: G0585R106